[Skip to Content]
[Skip to Content Landing]
Article
August 1960

The Course of Retinopathy in Treated Malignant Hypertension

Author Affiliations
Canton, Ohio; Iowa City; Cleveland
From the Department of Ophthalmology and the Research Division of the Cleveland Clinic Foundation and the Frank E. Bunts Educational Institute.
Arch Intern Med. 1960;106(2):205-212. doi:10.1001/archinte.1960.03820020045007
Abstract

The concurrent development of papilledema, retinal hemorrhages, and exudates in the course of hypertensive disease is regarded as a cardinal sign of necrotizing arteriolar disease (accelerated or malignant hypertension). Hence, these retinal signs have serious prognostic significance.1 In recent years, effective antihypertensive treatment has improved the immediate prognosis of malignant hypertension; with adequate blood-pressure control, papilledema, retinal hemorrhages, and exudates disappear and extraretinal signs of progressive hypertensive vascular disease remit.

The purpose of this report is to review the retinal abnormalities of patients with malignant hypertension with regard to their prognostic significance; to describe the effect of antipressor therapy on these abnormalities, and to show the association of the retinal changes with the effects of treatment on the extraretinal manifestations of the disease.

Methods and Material 

Patients Studied.  —The group was composed of 96 patients with apparent "primary" or "essential" hypertension in the malignant phase; all but one had

References
1.
Keith, N. M.; Wagener, H. P., and Barker, N. W.:  Some Different Types of Essential Hypertension: Their Course and Prognosis ,  Am. J.M. Sc. 197:322 ( (March) ) 1939.Crossref
2.
Wagener, H. P.; Clay, G. G., and Gipner, J. F.:  Classification of Retinal Lesions in Presence of Vascular Hypertension: Report Submitted by Committee ,  Tr. Am. Ophth. Soc. 45:57, 1947.
3.
Lockhart, G., III:  Changes in the Fundus Oculi in Relation to Hypertension ,  Cleveland Clin. Quart. 22:139 ( (Oct.) ) 1955.Crossref
4.
Corcoran, A. C.; Dustan, H. P.; Taylor, R. D., and Page, I. H.:  Management of Hypertensive Disease ,  Am. J. Med. 17:383 ( (Sept.) ) 1954.Crossref
5.
Evelyn, K. A.; Nicholis, J. V., and Turnbull, W.:  A Method for Grading and Recording the Retinal Changes in Essential Hypertension ,  Am. J. Ophth. 45 (Pt. 2): 165 ( (April) ) 1958.
6.
Kirkendall, W. M., and Armstrong, M. L.:  Effect of Blood Pressure Reduction on Vascular Changes in the Eye , in  Hypertension, the First Hahnemann Symposium on Hypertensive Disease , Philadelphia and London, W. B. Saunders Company, 1959.
7.
Friedenwald, J. S., et al.:  Ophthalmic Pathology , Philadelphia, W. B. Saunders Company, 1952.
8.
Kearns, T. P.:  Symposium on Hematologic Disorders: Changes in the Ocular Fundus in Blood Diseases ,  M. Clin. North America 40:1209 ( (July) ) 1956.
9.
Maumenee, A. E.:  Ocular Manifestations of Collagen Diseases ,  A.M.A. Arch. Ophth. 56:557 ( (Oct.) ) 1956.Crossref
10.
Clifton, F., and Greer, C. H.:  Ocular Changes in Acute Systemic Lupus Erythematosus ,  Brit. J. Ophth. 39:1 ( (Jan.) ) 1955.Crossref
11.
Byrom, F. B.:  The Pathogenesis of Hypertensive Encephalopathy and Its Relation to the Malignant Phase of Hypertension ,  Lancet 2:201 ( (July 31) ) 1954.Crossref
12.
Masson, G. M. C.; Plahl, G.; Corcoran, A. C., and Page, I. H.:  Accelerated Hypertensive Vascular Disease From Saline and Renin in Nephrectomized Dogs ,  A.M.A. Arch. Path. 55:85 ( (Feb.) ) 1953.
13.
Keith, N. M., and Wagener, H. P.:  Recession of Neuroretinopathy During the Course of Malignant Hypertension ,  A.M.A. Arch. Int. Med. 87:25 ( (Jan.) ) 1951.Crossref
14.
Taylor, R. D.; Corcoran, A. C., and Page, I. H.:  Increased Cerebrospinal Fluid Pressure and Papilledema in Malignant Hypertension ,  A.M.A. Arch. Int. Med. 93:818 ( (June) ) 1954.Crossref
15.
Pickering, G. W.:  High Blood Pressure , New York, Grune & Stratton, Inc., 1955.
16.
Corcoran, A. C.:  Relationship of Hypertension to Cerebral Vascular Disease , in Wright, J. R. and Millikon, C. H. (Editors):  Cerebral Vascular Diseases , New York, Grune & Stratton, Inc., 1958.
17.
Corcoran, A. C.; Lewis, L. A.; Dustan, H. P., and Page, I. H.:  Atherosclerotic Complications in Hypertensive Disease ,  Ann. New York Acad. Sc. 64:620 ( (Nov. 16) ) 1956.Crossref
18.
Dustan, H. P.; Schneckloth, R. E.; Corcoran, A. C., and Page, I. H.:  The Effectiveness of Long-Term Treatment of Malignant Hypertension ,  Circulation 18:644 ( (Oct.) ) 1958.Crossref
×